NR3C2 and obstructive sleep apnea syndrome: Conversely, several studies with small sample size and short treatment duration with CPAP did not reveal the anticipated reduction in the RAAS components [319,329,330,331,332,333], further justifying the need to include MR antagonists as an add-on adjuvant therapy in OSA patients.